We also treated GBM cells with etomoxir (200 μM), a potent CPT1 pharmacological inhibitor, in the presence of oleic acid and confirmed a significant inhibition of cell proliferation (Supplementary Fig. S4). Here, CPT1A is linked to glioblastoma.